Effect of astragalus mongholicus injection liquid on the immunity function in children with congenital heart disease (CHD) after undergoing cardiopulmonary bypass surgery

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 20, 2011, Pages 2317-2322

  Tong, Li ^a   Shaoyi, Yu ^a   Ge, Zhang ^b   Weizhe, Huang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Astragalus mongholicus injection liquid; Cardiopulmonary bypass surgery; Congenital heart disease (CHD); sVCAM 1

Indexed keywords

HERBACEOUS AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSTIMULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; ASTRAGALUS MONGHOLICUS; ASTRAGALUS PLANT; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; LIQUID; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 82755165289     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.630     Document Type: Article

References (24)

1. Beutler B, Cerami A (1986). Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature, 320: 584.
2. Beutler B, Cerami A (1988). Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem., 57: 505.
3. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986). Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science, 232:978.
4. Cerinic MM, Valentini G, Sorano GG, D'Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Pignone A, Guiducci S, Del Rosso A, Kalfin R, Das D, Marongiu F (2003). Blood coagulation, fibrinolysis and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum, 32: 285-295.
5. Chen LX, Liao JZ, Guo WQ (1995). Effects of Astragalus membranaceus on left ventricular function and oxygen free radical in acute myocardial infarction patients and mechanisms of its cardiotonic action. Zhongguo Zhong Xi Yi Jie He Ha Zhi, 15: 141-143.
6. Couriel J (2002). Assessment of the child with recurrent chest infections. Br. Med. Bull. 61(1): 115-132.
7. Cui R, He JC, Wang B, Zhang F, Chen GY, Yin S, Shen H (2003). Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother. Pharmacol., 51: 75-80.
8. Hwang Y-S, Tsai W-C, Lu Y-H, Lin C-C, Tsai K-Y (2005). Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: An observational, controlled pilot study in Taiwanese adults. Curr. Therap. Res., 66: 181-194.
9. Khan ZA, Chakrabarti S (2007). Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp. Diabetes Res., 2007: 31867.
10. Kuryliszyn Moskal A, Klimiuk PA, Sierakowski S (2005). Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: Relationship to organ systemic involvement. Clin. Rheumatol, 24: 111-116.
11. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, Kirklin JK (2009). The Effect of Age, Diagnosis, and Previous Surgery in Children and Adults Undergoing Heart Transplantation for Congenital Heart Disease. J. Am. Coll. Cardiol. 54:160-165.
12. Lin LZ, He XG, Lindenmaier M, Nolan G, Yang J, Cleary M, Qiu SX, Cordell GA (2000). Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus. J. Chromatogr. A, 876: 87-95.
13. Miller A, Riehle-Colarusso T, Alverson CJ, Frías JL, Correa A (2011). Congenital Heart Defects and Major Structural Noncardiac Anomalies, Atlanta, Georgia, 1968 to 2005. J Pediatrics, 159: 70-78.e2.
14. Monograph (2003). Astragalus membranaceus. Altern. Med. Rev., 8: 72-77.
15. Old LJ (1987). Tumor necrosis factor: another chapter in the long history of endotoxin. Nature, 330: 602.
16. Seibold JR, Ruddy SS, Harris ED, Sledge CB, Kelley WN (2001). Editors, Kelley's textbook of rheumatology, (6th ed.), W.B. Saunders Company, Philadelphia, pp. 1211-1240.
17. Shao BM, Xu W, Dai H, Yu P, Li Z, Gao XM (2004), A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem. Biophys. Res. Commun., 320: 1103-1111.
18. Sinclair S (1998). Chinese herbs: A clinical review of Astragalus, Ligusticum, and Schizandrae. Altern. Med. Rev., 3: 338-344.
19. Springer TA (1990). Adhesion receptors of the immune system. Nature, 346: 425-434.
20. Toda S, Shirataki Y (1999). Inhibitory effects of Astragali radix, a crude drug in oriental medicines, on lipid peroxidation and protein oxidative modifications by copper. J. Ethnopharmacol., 68: 331-333.
21. Verheugt CL, Uiterwaal CSPM, Grobbee DE, Mulder BJM (2008). Longterm prognosis of congenital heart defects: A systematic review. Int. J. Cardiol., 131: 25-32.
22. Wang D, Shen W, Tian Y, Sun Z, Jiang C, Yuan S (1996). Protective effect of active components extracted from radix Astragali on human erythrocyte membrane damages caused by reactive oxygen species, Zhongguo Zhong Yao Za Zhi, 21: 746-748,763.
23. Zee-Cheng RK (1992). Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Findings Exp. Clin. Pharmacol., 14: 725-736.
24. Ziegler EJ (1988). Tumor necrosis factor in humans. N. Engl. J. Med., 318: 1533.